Bile acid metabolism and signaling, the microbiota, and metabolic disease

J Cai, B Rimal, C Jiang, JYL Chiang… - Pharmacology & …, 2022 - Elsevier
The diversity, composition, and function of the bacterial community inhabiting the human
gastrointestinal tract contributes to host health through its role in producing energy or …

Bile acid signaling in metabolic disease and drug therapy

T Li, JYL Chiang - Pharmacological reviews, 2014 - ASPET
Bile acids are the end products of cholesterol catabolism. Hepatic bile acid synthesis
accounts for a major fraction of daily cholesterol turnover in humans. Biliary secretion of bile …

[HTML][HTML] Bile acid metabolism and signaling

JYL Chiang - Comprehensive physiology, 2013 - ncbi.nlm.nih.gov
Bile acids are important physiological agents for intestinal nutrient absorption and biliary
secretion of lipids, toxic metabolites, and xenobiotics. Bile acids also are signaling …

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of …

PS Jellinger, Y Handelsman, PD Rosenblit… - Endocrine Practice, 2017 - Elsevier
Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Beyond intestinal soap—bile acids in metabolic control

F Kuipers, VW Bloks, AK Groen - Nature Reviews Endocrinology, 2014 - nature.com
Over the past decade, it has become apparent that bile acids are involved in a host of
activities beyond their classic functions in bile formation and fat absorption. The identification …

Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

AC Calkin, P Tontonoz - Nature reviews Molecular cell biology, 2012 - nature.com
Nuclear receptors are integrators of hormonal and nutritional signals, mediating changes to
metabolic pathways within the body. Given that modulation of lipid and glucose metabolism …

Metformin, macrophage dysfunction and atherosclerosis

X Feng, W Chen, X Ni, PJ Little, S Xu, L Tang… - Frontiers in …, 2021 - frontiersin.org
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to
treat many diseases. More and more evidence shows that metformin can regulate the …

A review of the efficacy and safety of oral antidiabetic drugs

SA Stein, EM Lamos, SN Davis - Expert opinion on drug safety, 2013 - Taylor & Francis
Introduction: Additional oral antidiabetic agents to metformin, sulfonylureas (SU) and
thiazolidinediones (TZD) are approved for the treatment of type 2 diabetes. Areas covered …

Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management

JM Chehade, M Gladysz, AD Mooradian - Drugs, 2013 - Springer
Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes
mellitus. Despite the mounting clinical trial data, the management of dyslipidemia other than …

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

DJ Pournaras, C Glicksman, RP Vincent… - …, 2012 - academic.oup.com
Gastric bypass leads to the remission of type 2 diabetes independently of weight loss. Our
hypothesis is that changes in bile flow due to the altered anatomy may partly explain the …